LEADER 01511nam  2200373Ia 450 
001 9910698137303321
005 20090320110024.0
035   $a(CKB)5470000002395609
035   $a(OCoLC)316532778
035   $a(EXLCZ)995470000002395609
100   $a20090320d2008      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aEvaluation and recommendation of pharmacopoeial texts for use in the ICH regions on Dissolution Test General Chapter$b[electronic resource]
210  1$a[Rockville, Md.?] :$c[U.S. Food and Drug Administration, Center for Biologics Evaluation and Research]
215   $a4 unnumbered pages, 3 pages $cdigital, PDF file
300   $a"Q4B annex 7."
300   $a"Current step 2 version, dated 13 November 2008."
300   $a"Draft consensus guideline."
320   $aIncludes bibliographical references (page 3).
517 1 $aQ4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions
517 3 $aICH regions on Dissolution Test General Chapter
606   $aDrugs$xSolubility$xTesting
615  0$aDrugs$xSolubility$xTesting.
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698137303321
996   $aEvaluation and recommendation of pharmacopoeial texts for use in the ICH regions on Dissolution Test General Chapter$93179741
997   $aUNINA